Academic History

Karie Runcie, MD, currently serves as an Assistant Professor of Medicine in the Division of Hematology/Oncology at Columbia University Irving Medical Center (CUIMC), affiliated with NewYork-Presbyterian Hospital in New York City. She earned her medical degree from Albert Einstein College of Medicine. From here, she pursued clinical training and ascended into her current academic position, where she contributes both to patient care and medical education.

Specialty in Hematology/Oncology & Clinical Research

Dr Runcie specializes in medical oncology, with a focus on hematology/oncology, providing expert care for patients across a spectrum of cancers through ColumbiaDoctors at CUIMC’s Herbert Irving Pavilion. She is the Principal Investigator on the phase II clinical trial ARCITECT, which investigates immunotherapy combinations for advanced renal cell carcinoma—underscoring her leadership in innovative kidney cancer research. Additionally, her involvement in multiple clinical trials, particularly in genitourinary oncology settings (including kidney and prostate cancers), highlights her active role in advancing cancer treatment paradigms